01015nas a2200397   4500000000100000008004100001260001300042653002500055653001200080653001200092653003700104653002200141653001600163653002300179653002700202653002300229653002300252653001200275653002000287653001600307653000900323653001400332653002500346653001600371653001500387653001500402653001700417100001500434700001700449700001800466245006100484856004100545300001000586490000700596022001400603       2001                            d  c2001 Mar10aAdministration, Oral10aAnimals10aDapsone10aDose-Response Relationship, Drug10aErythrocyte Count10aHemoglobins10aHistocytochemistry10aHorseradish Peroxidase10aImmunity, Cellular10aLeprostatic Agents10aleprosy10aLeukocyte Count10aLymphocytes10aMice10aMonocytes10aMycobacterium leprae10aNeutrophils10aPeroxidase10aPhagocytes10aTime Factors1 aMaslov A K1 aLuzhnova S A1 aKalyanina O V00aPeroxidase in therapy of experimentally induced leprosy.  uhttp://ila.ilsl.br/pdfs/v69n1a11.pdf  a49-520 v69  a0148-916X